INO
Price:
$1.115
Market Cap:
$59.75M
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen. This innovative approach is supported by its CELLECTRA smart device technology, which efficiently delivers the DNA plasmids. Inovio is actively engaged in and planning clinical trials for its DNA medicines across a wide array of conditions. ...[Read more]
Industry
Biotechnology
IPO Date
1998-12-08
Stock Exchange
NASDAQ
Ticker
INO
According to Inovio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.71. This represents a change of -157.90% compared to the average of 1.23 of the last 4 quarters.
The mean historical PE Ratio of Inovio Pharmaceuticals, Inc. over the last ten years is -36.01. The current -0.71 PE Ratio has changed 97.19% with respect to the historical average. Over the past ten years (40 quarters), INO's PE Ratio was at its highest in in the September 2020 quarter at 290.00. The PE Ratio was at its lowest in in the June 2017 quarter at -180.92.
Average
-36.01
Median
-41.50
Minimum
-99.25
Maximum
-0.46
Discovering the peaks and valleys of Inovio Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.12%
Maximum Annual PE Ratio = -0.46
Minimum Annual Increase = -96.84%
Minimum Annual PE Ratio = -99.25
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.96 | 107.50% |
| 2024 | -0.46 | -53.90% |
| 2023 | -1.00 | -24.47% |
| 2022 | -1.33 | -96.84% |
| 2021 | -42.17 | -57.51% |
| 2020 | -99.25 | 143.12% |
| 2019 | -40.82 | -10.70% |
| 2018 | -45.71 | -0.38% |
| 2017 | -45.89 | -44.35% |
| 2016 | -82.46 | -56.03% |
The current PE Ratio of Inovio Pharmaceuticals, Inc. (INO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.81
5-year avg
-9.19
10-year avg
-36.01
Inovio Pharmaceuticals, Inc.’s PE Ratio is greater than Acumen Pharmaceuticals, Inc. (-1.21), greater than Opus Genetics, Inc. (-3.11), less than Agenus Inc. (1.73), greater than Seer, Inc. (-1.40), less than Spero Therapeutics, Inc. (8.45), greater than Fate Therapeutics, Inc. (-1.92), greater than Seres Therapeutics, Inc. (-1.28), less than VistaGen Therapeutics, Inc. (-0.36), greater than Alector, Inc. (-1.47), greater than Actuate Therapeutics Inc (-2.09),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.21 | $136.90M | |
| -3.11 | $336.04M | |
| 1.73 | $124.93M | |
| -1.40 | $95.67M | |
| 8.45 | $132.02M | |
| -1.92 | $243.61M | |
| -1.28 | $64.01M | |
| -0.36 | $21.96M | |
| -1.47 | $194.29M | |
| -2.09 | $49.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inovio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Inovio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Inovio Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Inovio Pharmaceuticals, Inc. (INO)?
What is the highest PE Ratio for Inovio Pharmaceuticals, Inc. (INO)?
What is the 3-year average PE Ratio for Inovio Pharmaceuticals, Inc. (INO)?
What is the 5-year average PE Ratio for Inovio Pharmaceuticals, Inc. (INO)?
How does the current PE Ratio for Inovio Pharmaceuticals, Inc. (INO) compare to its historical average?